NEW YORK (GenomeWeb News) – Nanosphere today said that its second-quarter revenues jumped 160 percent year over year, but the firm fell short of Wall Street's estimate for the top line.

The Northbrook, Ill.-based molecular diagnostics firm reported preliminary Q2 revenues of $1.3 million for the three-month period ended June 30, up from $500,000 for the second quarter of 2011. However, it missed analysts' consensus estimate for revenues of $1.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.